Podcast Episodes
Back to Search
Why Everyone Should Be Screened for HCV and Treated If They Have It: Conversations Between Patient and Physician
Episode 165
In this episode, Norah Terrault, MD, MPH, and a patient who has been cured of hepatitis C virus (HCV) infection discuss the importance of universal H…
4 years ago
Key Decisions in HIV Care: Considering Novel Therapies for HIV
Episode 164
In this episode from the series “Key Decisions in HIV Care,” Cristina Mussini, MD, and William R. Short, MD, MPH, AAHIVS, discuss novel therapies for…
4 years ago
A Model Intervention: Aiming for HCV Elimination in HIV-Positive MSM
Episode 163
In this podcast, Dr Dominique Laurent Braun discusses his micro-elimination program, the Swiss HCVree trial, designed to prevent hepatitis C virus (H…
4 years ago
COVID-19: Which Drug, When, and Why? Antiviral Agents
Episode 162
Antiviral agents continue to be effective against different strains of SARS-CoV-2 when used early in the disease course. In this episode, learn about…
4 years ago
COVID-19: Which Drug, When, and Why? Monoclonal Antibody Treatments
Episode 161
The place of monoclonal antibodies in COVID-19 is changing. In this episode, learn about their role in prophylaxis of patients who are at high risk o…
4 years ago
How Stigma and Socioeconomic Barriers Impede HCV Care: Conversations Between Patient and Physician
Episode 160
In this episode, Oluwaseun Falade-Nwulia, MBBS, MPH, and a patient with previous injection drug use who has been cured of HCV infection discuss criti…
4 years ago
Long COVID
Episode 158
In this episode, Renslow Sherer, MD, discusses what is known to date regarding long COVID, also known as postacute sequelae of COVID-19 infection, in…
4 years ago
Importance of Screening for HCC in HBV: Patient and Physician Sharing Session #7
Episode 157
In episode 7 of a series of sharing sessions between a physician and patient, Ming-Lung Yu, MD, PhD, and his patient, who is living with chronic hepa…
4 years ago
COVID-19: Which Drug, When, and Why? Anti-inflammatory Agents and Immunomodulators
Episode 156
Anti-inflammatory agents and immunomodulators are key components to treating patients who are severely or critically ill due to a COVID-19 infection.…
4 years, 1 month ago
Key Decisions in HIV Care: Managing ART With Opportunistic Infections
Episode 155
In this episode from the series “Key Decisions in HIV Care,” Cristina Mussini, MD, and William R. Short, MD, MPH, AAHIVS, discuss important considera…
4 years, 1 month ago